Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cachexia × Magnetic Resonance Spectroscopy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 130 Breast Neoplasms 92 Lung Neoplasms 67 Brain Neoplasms 62 Carcinoma, Non-Small-Cell Lung 52 Glioblastoma 50 Glioma 46 Pancreatic Neoplasms 34 Neoplasms 33 Neoplasm Metastasis 33 Carcinoma, Hepatocellular 26 Colorectal Neoplasms 25 Carcinoma, Renal Cell 25 Lymphoma, Large B-Cell, Diffuse 24 Multiple Myeloma 23 Melanoma 20 Squamous Cell Carcinoma of Head and Neck 19 Ovarian Neoplasms 19 Lymphoma, Follicular 17 Rectal Neoplasms 16 Head and Neck Neoplasms 16 Astrocytoma 16 Uterine Cervical Neoplasms 15 Urinary Bladder Neoplasms 15 Esophageal Neoplasms 15 Lymphoma 13 Sarcoma 12 Oropharyngeal Neoplasms 12 Lymphoma, B-Cell 12 Leukemia, Lymphocytic, Chronic, B-Cell 12

Interventions

Megestrol Acetate 7 Exercise 5 Standard of Care 4 Olanzapine 3 Blood Specimen Collection 3 dermcidin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Ibuprofen 2 Enteral Nutrition 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 bermekimab 1 anamorelin 1 Vitamin D 1 Ultrasonography 1 Retrospective Studies 1 Radiotherapy 1 Powders 1 Omacor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06112964 2024-07-17

CANCOG

University of Cambridge

Anorexia, Cachexia, Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡